Your browser doesn't support javascript.
loading
Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants.
Prokopenko, Inga; Miyakawa, Gentaro; Zheng, Bang; Heikkinen, Jani; Petrova Quayle, Daniela; Udeh-Momoh, Chinedu; Claringbould, Annique; Neumann, Juliane; Haytural, Hazal; Kaakinen, Marika A; Loizidou, Elena; Meissner, Esther; Bertram, Lars; Gveric, Djordje O; Gentleman, Steve M; Attems, Johannes; Perneczky, Robert; Arzberger, Thomas; Muglia, Pierandrea; Lill, Christina M; Parkkinen, Laura; Middleton, Lefkos T.
Afiliación
  • Prokopenko I; Section of Genomics of Common Disease, Department of Medicine, Imperial College London, London, UK.
  • Miyakawa G; Section of Statistical Multi-Omics, Department of Clinical and Experimental Medicine, School of Biosciences and Medicine, University of Surrey, Guildford, UK.
  • Zheng B; Genetic and Molecular Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany.
  • Heikkinen J; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Petrova Quayle D; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, UK.
  • Udeh-Momoh C; Section of Genomics of Common Disease, Department of Medicine, Imperial College London, London, UK.
  • Claringbould A; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, UK.
  • Neumann J; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, UK.
  • Haytural H; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, UK.
  • Kaakinen MA; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.
  • Loizidou E; Nuffield Department of Clinical Neuroscience, Neuropathology and Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
  • Meissner E; Nuffield Department of Clinical Neuroscience, Neuropathology and Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
  • Bertram L; Section of Genomics of Common Disease, Department of Medicine, Imperial College London, London, UK.
  • Gveric DO; Centre for Pharmacology and Therapeutics, Department of Medicine, Imperial College London, London, UK.
  • Gentleman SM; Section of Genomics of Common Disease, Department of Medicine, Imperial College London, London, UK.
  • Attems J; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Perneczky R; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, UK.
  • Arzberger T; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany.
  • Lill CM; Multiple Sclerosis and Parkinson's Tissue Bank, Imperial College London, London, UK.
  • Parkkinen L; Neuropathology Unit, Department of Medicine, Imperial College London, London, UK.
  • Middleton LT; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Alzheimers Dement (N Y) ; 5: 814-824, 2019.
Article en En | MEDLINE | ID: mdl-31788537
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Alzheimers Dement (N Y) Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Alzheimers Dement (N Y) Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido